Oric Pharmaceuticals
ORIC
ORIC
149 hedge funds and large institutions have $1.28B invested in Oric Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 58 increasing their positions, 34 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.11% more ownership
Funds ownership: 109.53% → 109.65% (+0.11%)
17% less funds holding in top 10
Funds holding in top 10: 12 → 10 (-2)
79% less call options, than puts
Call options by funds: $447K | Put options by funds: $2.18M
Holders
149
Holding in Top 10
10
Calls
$447K
Puts
$2.18M
Top Buyers
| 1 | +$61.3M | |
| 2 | +$32.9M | |
| 3 | +$18.3M | |
| 4 |
RA
Royce & Associates
New York
|
+$14.7M |
| 5 |
BlackRock
New York
|
+$14.4M |
Top Sellers
| 1 | -$10.8M | |
| 2 | -$4.93M | |
| 3 | -$4.2M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$3.1M |
| 5 |
SCM
Superstring Capital Management
New York
|
-$3.07M |
